Skip to main content

Table 1 Estimation results for the program effects on employment and mortality

From: Are there employment and income gains of a national breast cancer screening program?

 

Employment

Mortality

 

Coef.

Std.Err.

Coef.

Std.Err.

Panel A: Difference from the baseline for BC diagnosed women, Eq. (1)

 No screening program, β0

−0.034***

(0.005)

0.018***

(0.002)

 Screening program, β1

−0.033***

(0.003)

0.017***

(0.001)

 Program effect, Eq. (1): (β1 − β0)

0.001

(0.006)

−0.001

(0.002)

Panel B: Differences from the baseline for BC diagnosed women by time since diagnosis, Eq. (2)

No screening program, \({\beta}_0^k\) s

  In year of diagnosis

−0.012

(0.008)

0.007**

(0.003)

  1 year after diagnosis

−0.040***

(0.008)

0.014***

(0.003)

  2 years after diagnosis

−0.054***

(0.009)

0.026***

(0.004)

  3 years after diagnosis

−0.067***

(0.010)

0.036***

(0.004)

  4 years after diagnosis

−0.065***

(0.011)

0.032***

(0.004)

  5 years after diagnosis

−0.067***

(0.012)

0.042***

(0.005)

  6 years after diagnosis

−0.058***

(0.015)

0.057***

(0.009)

Screening program, \({\beta}_1^k\) s

  In year of diagnosis

−0.019***

(0.007)

0.010***

(0.002)

  1 year after diagnosis

−0.035***

(0.007)

0.016***

(0.003)

  2 years after diagnosis

−0.047***

(0.008)

0.023***

(0.003)

  3 years after diagnosis

−0.064***

(0.008)

0.031***

(0.003)

  4 years after diagnosis

−0.054***

(0.009)

0.033***

(0.004)

  5 years after diagnosis

−0.052***

(0.010)

0.035***

(0.004)

  6 years after diagnosis

−0.048***

(0.012)

0.041***

(0.006)

Program effect, \(\left({\beta}_1^k-{\beta}_0^k\right)\) s

  In year of diagnosis

−0.007

(0.010)

0.003

(0.004)

  1 year after diagnosis

0.004

(0.011)

0.002

(0.004)

  2 years after diagnosis

0.007

(0.012)

−0.002

(0.005)

  3 years after diagnosis

0.003

(0.013)

−0.005

(0.006)

  4 years after diagnosis

0.011

(0.014)

0.001

(0.006)

  5 years after diagnosis

0.015

(0.016)

−0.007

(0.007)

  6 years after diagnosis

0.010

(0.019)

−0.016

(0.010)

Panel C: Specification tests (p-values)

 No program effects

0.909

 

0.372

 

 No time since diagnosis effects

0.000***

 

0.000***

 

 No age at diagnosis effects

0.589

 

0.152

 

 Common trend before the time of diagnosis

0.981

   

 Hausman test (H0: random effects)

0.000***

 

0.000***

 

R2 (within)

0.006

 

0.007

 

Number of observations

1,242,852

 

1,245,746

 

Number of years

7

 

7

 

Number of women

229,011

 

229,357

 
  1. Notes. BC Breast cancer. The models control for year, age, household size, number of adults, and for panel C, age at diagnosis. For Panel C: No program effects, H0: \(\left({\beta}_1^0-{\beta}_0^0\right)=..\left({\beta}_1^6-{\beta}_0^6\right)=0\); No time since diagnosis effects, H0: \({\beta}_0^0=..={\beta}_0^6\), \({\beta}_1^0=..={\beta}_1^6\), No age at diagnosis effects, H0: γ47 = γ48, γ50 = γ52 = γ53. The standard errors are clustered by individual. Levels of significance: *** p < 0.01, ** p < 0.05, * p < 0.10